William P. Kane's most recent trade in Karuna Therapeutics Inc was a trade of 10,306 Restricted Stock Units done . Disclosure was reported to the exchange on Feb. 13, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Karuna Therapeutics Inc | William P. Kane | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2024 | 10,306 | 10,306 | - | - | Restricted Stock Units | |
Karuna Therapeutics Inc | P. Kane William | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 316.30 per share. | 28 Dec 2023 | 3,828 | 13,828 (0%) | 0% | 316.3 | 1,210,796 | Common Stock |
Karuna Therapeutics Inc | William P. Kane | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2023 | 29,937 | 29,937 | - | - | Stock Option (Right to Buy) | |
Karuna Therapeutics Inc | William P. Kane | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2023 | 17,656 | 17,656 (0%) | 0% | 0 | Common Stock | |
BioXcel Therapeutics Inc | William P. Kane | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Aug 2021 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) |